Trabectedin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Trabectedin" in English language version.

refsWebsite

Global rank English rank

12nih.gov

4^th place

8doi.org

2^nd place

6web.archive.org

1^st place

4europa.eu

68^th place

117^th place

3harvard.edu

18^th place

17^th place

2semanticscholar.org

11^th place

8^th place

2pharmamar.com

low place

2cancernetwork.com

low place

1tga.gov.au

3,984^th place

2,622^nd place

1medicines.org.uk

3,823^rd place

2,387^th place

1newscientist.com

774^th place

716^th place

1reuters.com

49^th place

47^th place

1pharmatimes.com

low place

1handle.net

102^nd place

76^th place

cancernetwork.com

"Trabectedin Superior to Dacarbazine for Leiomyosarcoma, Liposarcoma". Cancer Network. 21 September 2015. Archived from the original on 5 March 2016.
"FDA Approves Trabectedin (Yondelis) for Advanced Soft-Tissue Sarcoma". Cancer Network. 26 October 2015. Archived from the original on 17 March 2016.

doi.org

Rinehart KL (January 2000). "Antitumor compounds from tunicates". Medicinal Research Reviews. 20 (1): 1–27. doi:10.1002/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A. PMID 10608919. S2CID 25117225.
Rath CM, Janto B, Earl J, Ahmed A, Hu FZ, Hiller L, et al. (November 2011). "Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743". ACS Chemical Biology. 6 (11): 1244–1256. doi:10.1021/cb200244t. PMC 3220770. PMID 21875091.
Corey EJ, Gin DY, Kania RS (1996). "Enantioselective Total Synthesis of Ecteinascidin 743". Journal of the American Chemical Society. 118 (38): 9202–9203. Bibcode:1996JAChS.118.9202C. doi:10.1021/ja962480t.
Cuevas C, Pérez M, Martín MJ, Chicharro JL, Fernández-Rivas C, Flores M, et al. (August 2000). "Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B". Organic Letters. 2 (16): 2545–2548. doi:10.1021/ol0062502. PMID 10956543.
D'Incalci M, Galmarini CM (August 2010). "A review of trabectedin (ET-743): a unique mechanism of action". Molecular Cancer Therapeutics. 9 (8): 2157–2163. doi:10.1158/1535-7163.MCT-10-0263. PMID 20647340. S2CID 6723817.
Chukwueke UN, Wen PY (2020). "Medical management of meningiomas". In McDermott MW (ed.). Meningiomas, Part II. Handbook of Clinical Neurology. Vol. 170. Elsevier. pp. 291–302. doi:10.1016/B978-0-12-822198-3.00048-3. ISBN 978-0-12-822198-3. PMC 6169485. PMID 32586501.
Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, et al. (February 2011). "Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells". Neoplasia. 13 (2): 145–153. doi:10.1593/neo.101202. PMC 3033593. PMID 21403840. and works cited therein.
Son K, Takhaveev V, Mor V, Yu H, Dillier E, Zilio N, et al. (February 2024). "Trabectedin derails transcription-coupled nucleotide excision repair to induce DNA breaks in highly transcribed genes". Nature Communications. 15 (1): 1388. Bibcode:2024NatCo..15.1388S. doi:10.1038/s41467-024-45664-7. hdl:20.500.11850/661709. PMC 10869700. PMID 38360910.

europa.eu

ema.europa.eu

"Yondelis EPAR". European Medicines Agency (EMA). 17 September 2018. Retrieved 30 September 2020.
"YONDELIS (trabectedin)" (PDF). Post-Authorization Summary of Positive Opinion. European Medicines Agency. 24 September 2009. Retrieved 12 November 2019.
"Yondelis". European Medicines Agency (EMA). 27 February 2020. Retrieved 30 September 2020.

emea.europa.eu

"CHMP evaluation" (PDF).

handle.net

hdl.handle.net

Son K, Takhaveev V, Mor V, Yu H, Dillier E, Zilio N, et al. (February 2024). "Trabectedin derails transcription-coupled nucleotide excision repair to induce DNA breaks in highly transcribed genes". Nature Communications. 15 (1): 1388. Bibcode:2024NatCo..15.1388S. doi:10.1038/s41467-024-45664-7. hdl:20.500.11850/661709. PMC 10869700. PMID 38360910.

harvard.edu

ui.adsabs.harvard.edu

Corey EJ, Gin DY, Kania RS (1996). "Enantioselective Total Synthesis of Ecteinascidin 743". Journal of the American Chemical Society. 118 (38): 9202–9203. Bibcode:1996JAChS.118.9202C. doi:10.1021/ja962480t.
Son K, Takhaveev V, Mor V, Yu H, Dillier E, Zilio N, et al. (February 2024). "Trabectedin derails transcription-coupled nucleotide excision repair to induce DNA breaks in highly transcribed genes". Nature Communications. 15 (1): 1388. Bibcode:2024NatCo..15.1388S. doi:10.1038/s41467-024-45664-7. hdl:20.500.11850/661709. PMC 10869700. PMID 38360910.

news.harvard.edu

Cromie WJ (4 May 2000). "Potent cancer drugs made -- Sea squirts provide recipe". Harvard University Gazette. Archived from the original on 3 June 2006.

medicines.org.uk

"Yondelis 1 mg powder for concentrate for solution for infusion - Summary of Product Characteristics (SmPC)". (emc). 21 September 2020. Retrieved 30 September 2020.

newscientist.com

Pain S (14 September 1996). "Hostages of the deep - Prospectors are taking to the seas in search of new and promising chemicals. But the better the drugs turn out to be, the greater the threat to the animals that produce them". New Scientist.

nih.gov

pubmed.ncbi.nlm.nih.gov

Rinehart KL (January 2000). "Antitumor compounds from tunicates". Medicinal Research Reviews. 20 (1): 1–27. doi:10.1002/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A. PMID 10608919. S2CID 25117225.
Rath CM, Janto B, Earl J, Ahmed A, Hu FZ, Hiller L, et al. (November 2011). "Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743". ACS Chemical Biology. 6 (11): 1244–1256. doi:10.1021/cb200244t. PMC 3220770. PMID 21875091.
Cuevas C, Pérez M, Martín MJ, Chicharro JL, Fernández-Rivas C, Flores M, et al. (August 2000). "Synthesis of ecteinascidin ET-743 and phthalascidin Pt-650 from cyanosafracin B". Organic Letters. 2 (16): 2545–2548. doi:10.1021/ol0062502. PMID 10956543.
D'Incalci M, Galmarini CM (August 2010). "A review of trabectedin (ET-743): a unique mechanism of action". Molecular Cancer Therapeutics. 9 (8): 2157–2163. doi:10.1158/1535-7163.MCT-10-0263. PMID 20647340. S2CID 6723817.
Chukwueke UN, Wen PY (2020). "Medical management of meningiomas". In McDermott MW (ed.). Meningiomas, Part II. Handbook of Clinical Neurology. Vol. 170. Elsevier. pp. 291–302. doi:10.1016/B978-0-12-822198-3.00048-3. ISBN 978-0-12-822198-3. PMC 6169485. PMID 32586501.
Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, et al. (February 2011). "Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells". Neoplasia. 13 (2): 145–153. doi:10.1593/neo.101202. PMC 3033593. PMID 21403840. and works cited therein.
Son K, Takhaveev V, Mor V, Yu H, Dillier E, Zilio N, et al. (February 2024). "Trabectedin derails transcription-coupled nucleotide excision repair to induce DNA breaks in highly transcribed genes". Nature Communications. 15 (1): 1388. Bibcode:2024NatCo..15.1388S. doi:10.1038/s41467-024-45664-7. hdl:20.500.11850/661709. PMC 10869700. PMID 38360910.

ncbi.nlm.nih.gov

Rath CM, Janto B, Earl J, Ahmed A, Hu FZ, Hiller L, et al. (November 2011). "Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product ET-743". ACS Chemical Biology. 6 (11): 1244–1256. doi:10.1021/cb200244t. PMC 3220770. PMID 21875091.
Chukwueke UN, Wen PY (2020). "Medical management of meningiomas". In McDermott MW (ed.). Meningiomas, Part II. Handbook of Clinical Neurology. Vol. 170. Elsevier. pp. 291–302. doi:10.1016/B978-0-12-822198-3.00048-3. ISBN 978-0-12-822198-3. PMC 6169485. PMID 32586501.
Grohar PJ, Griffin LB, Yeung C, Chen QR, Pommier Y, Khanna C, et al. (February 2011). "Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells". Neoplasia. 13 (2): 145–153. doi:10.1593/neo.101202. PMC 3033593. PMID 21403840. and works cited therein.
Son K, Takhaveev V, Mor V, Yu H, Dillier E, Zilio N, et al. (February 2024). "Trabectedin derails transcription-coupled nucleotide excision repair to induce DNA breaks in highly transcribed genes". Nature Communications. 15 (1): 1388. Bibcode:2024NatCo..15.1388S. doi:10.1038/s41467-024-45664-7. hdl:20.500.11850/661709. PMC 10869700. PMID 38360910.

dailymed.nlm.nih.gov

"Yondelis- trabectedin injection, powder, lyophilized, for solution". DailyMed. 22 September 2020. Retrieved 30 September 2020.

pharmamar.com

"PharmaMar website". Archived from the original on September 18, 2008.
"Yondelis (trabectedin)". PharmaMar. Archived from the original on 13 February 2012.

pharmatimes.com

Grogan K (3 May 2011). "J&J pulls submission for Zeltia's Yondelis". PharmaTimes Magazine. London, England. Online PharmaTimes. Archived from the original on 2 October 2011. Retrieved 7 May 2011.

reuters.com

"S.Korea approves Zeltia cancer drug Yondelis". Reuters. 8 May 2008. Retrieved 30 September 2020.

semanticscholar.org

api.semanticscholar.org

Rinehart KL (January 2000). "Antitumor compounds from tunicates". Medicinal Research Reviews. 20 (1): 1–27. doi:10.1002/(SICI)1098-1128(200001)20:1<1::AID-MED1>3.0.CO;2-A. PMID 10608919. S2CID 25117225.
D'Incalci M, Galmarini CM (August 2010). "A review of trabectedin (ET-743): a unique mechanism of action". Molecular Cancer Therapeutics. 9 (8): 2157–2163. doi:10.1158/1535-7163.MCT-10-0263. PMID 20647340. S2CID 6723817.

tga.gov.au

"Yondelis". Therapeutic Goods Administration (TGA). 3 May 2021. Retrieved 6 September 2021.

web.archive.org

Cromie WJ (4 May 2000). "Potent cancer drugs made -- Sea squirts provide recipe". Harvard University Gazette. Archived from the original on 3 June 2006.
"PharmaMar website". Archived from the original on September 18, 2008.
"Trabectedin Superior to Dacarbazine for Leiomyosarcoma, Liposarcoma". Cancer Network. 21 September 2015. Archived from the original on 5 March 2016.
"FDA Approves Trabectedin (Yondelis) for Advanced Soft-Tissue Sarcoma". Cancer Network. 26 October 2015. Archived from the original on 17 March 2016.
Grogan K (3 May 2011). "J&J pulls submission for Zeltia's Yondelis". PharmaTimes Magazine. London, England. Online PharmaTimes. Archived from the original on 2 October 2011. Retrieved 7 May 2011.
"Yondelis (trabectedin)". PharmaMar. Archived from the original on 13 February 2012.